CoChat

Metabolic rewiring and redox alterations in malignant pleural mesothelioma

Open access

The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.

Abstract

Abstract Malignant pleural mesothelioma (MPM) is a rare malignancy of mesothelial cells with increasing incidence, and in many cases, dismal prognosis due to its aggressiveness and lack of effective therapies. Environmental and occupational exposure to asbestos is considered the main aetiological factor for MPM. Inhaled asbestos fibres accumulate in the lungs and induce the generation of reactive oxygen species (ROS) due to the presence of iron associated with the fibrous silicates and to the activation of macrophages and inflammation. Chronic inflammation and a ROS-enriched microenvironment can foster the malignant transformation of mesothelial cells. In addition, MPM cells have a highly glycolytic metabolic profile and are positive in 18 F-FDG PET analysis. Loss-of-function mutations of BRCA-associated protein 1 (BAP1) are a major contributor to the metabolic rewiring of MPM cells. A subset of MPM tumours show loss of the methyladenosine phosphorylase (MTAP) locus, resulting in profound alterations in polyamine metabolism, ATP and methionine salvage pathways, as well as changes in epigenetic control of gene expression. This review provides an overview of the perturbations in metabolism and ROS homoeostasis of MPM cells and the role of these alterations in malignant transformation and tumour progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41416-019-0661-9

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic representation of asbestos-induced mesothelial cell transformation. ROS generated by asbestos fibres induce necrosis of mesothelial cells and release of HMGB1. The latter activates macrophages that in turn secrete TNF-α. TNF-α inhibits the necrosis of mesothelial cells and induces cell proliferation. This and subsequent figures were created using Smart Servier Medical Art (https://smart.servier.com/).
Fig. 1 Schematic representation of asbestos-induced mesothelial cell transformation. ROS generated by asbestos fibres induce necrosis of mesothelial cells and release of HMGB1. The latter activates macrophages that in turn secrete TNF-α. TNF-α inhibits the necrosis of mesothelial cells and induces cell proliferation. This and subsequent figures were created using Smart Servier Medical Art (https://smart.servier.com/).CC BY · PubMed Central
Fig. 2 Mitogenic signalling pathways activated by asbestos. Exposure to asbestos leads to the activation of key mitogenic pathways. See main text for definitions.
Fig. 2 Mitogenic signalling pathways activated by asbestos. Exposure to asbestos leads to the activation of key mitogenic pathways. See main text for definitions.CC BY · PubMed Central
Fig. 3 Metabolic rewiring and ROS production controlled by BAP1. (Left) BAP1 deubiquitylates and activates IP3R3, thus increasing the concentration of calcium in mitochondria, which promotes the activity of TCA cycle. The consequent enhancement of electron flow (red arrow) through the electron transport chain (ETC) also drives ROS production. (Right) When BAP1 expression is lost or reduced, the ubiquitination (Ub) of IP3R3 impairs its activity, reducing calcium levels in mitochondria. This reduces the activity of the TCA cycle and electron flow across the ETC, thus decreasing ROS production and favouring a switch to glycolytic metabolism (Warburg effect). Lactate excreted in the microenvironment generates a pro-tumorigenic environment.
Fig. 3 Metabolic rewiring and ROS production controlled by BAP1. (Left) BAP1 deubiquitylates and activates IP3R3, thus increasing the concentration of calcium in mitochondria, which promotes the activity of TCA cycle. The consequent enhancement of electron flow (red arrow) through the electron transport chain (ETC) also drives ROS production. (Right) When BAP1 expression is lost or reduced, the ubiquitination (Ub) of IP3R3 impairs its activity, reducing calcium levels in mitochondria. This reduces the activity of the TCA cycle and electron flow across the ETC, thus decreasing ROS production and favouring a switch to glycolytic metabolism (Warburg effect). Lactate excreted in the microenvironment generates a pro-tumorigenic environment.CC BY · PubMed Central
Fig. 4 Schematic diagram of the MTAP pathway. a. 5′-methylthioadenosine phosphorylase (MTAP) converts MTA into adenine and 5-methylthioribose-1-phosphate (5-MTR-1-P). b. Loss of MTAP results in accumulation of MTA, which inhibits protein arginine transferase 5 (PRMT5), an enzyme involved in the methylation of Sm proteins and histones.
Fig. 4 Schematic diagram of the MTAP pathway. a. 5′-methylthioadenosine phosphorylase (MTAP) converts MTA into adenine and 5-methylthioribose-1-phosphate (5-MTR-1-P). b. Loss of MTAP results in accumulation of MTA, which inhibits protein arginine transferase 5 (PRMT5), an enzyme involved in the methylation of Sm proteins and histones.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 130 references

Cited by

See all 53

Metadata

Authors
Urso, L., Cavallari, I., Sharova, E., Ciccarese, F., Pasello, G., & Ciminale, V.
Affiliations
  • University of Padua (IT)
  • Istituto Oncologico Veneto (IT)
Corresponding author
Ciminale, Vincenzo
Venue
British Journal of Cancer
Published
2019-12-10
Volume
122
Issue
1
Pages
52-61
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2992175458
Cited by
47
References
130
Citations by year
2026: 8 · 2025: 8 · 2024: 5 · 2023: 10 · 2022: 6 · 2021: 7 · 2020: 1 · 2019: 1
FWCI
0.63
Type
journal article
Language
en
Open access
Licence
Locations
  • British Journal of Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
This work was supported by 5 X 1000 funds of the Veneto Institute of Oncology IOV – IRCCS
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
Keywords
malignant pleural mesothelioma, metabolic reprogramming, redox homeostasis, reactive oxygen species, asbestos exposure, glycolysis, BAP1 mutation, MTAP loss, polyamine metabolism, methionine salvage pathway, epigenetic regulation, tumor microenvironment, malignant transformation, tumor progression
MeSH terms
Loss of Function Mutation, Mesothelioma, Malignant, Animals, Antineoplastic Agents, Asbestos, Cell Transformation, Neoplastic, Cisplatin, Humans, Lung Neoplasms, Mesothelioma, Oxidation-Reduction, Pleural Neoplasms, Transforming Growth Factor beta, Reactive Oxygen Species, Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic rewiring and redox alterations in malignant pleural mesothelioma. https://app.cochat.ai/papers/10.1038/s41416-019-0661-9
The paper
Urso, L., Cavallari, I., Sharova, E., Ciccarese, F., Pasello, G., & Ciminale, V. (2020). Metabolic rewiring and redox alterations in malignant pleural mesothelioma. British Journal of Cancer. https://doi.org/10.1038/s41416-019-0661-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.